Banner Corporation

1 day ago · fool.com

Disciplined credit standards and rising asset yields are fueling both loan growth and net interest income expansion.

11 days ago · marketbeat.com

Banner NASDAQ: BANR reported third-quarter 2026 net profit available to common shareholders of $47.7 million, or $1.36 per diluted share, as the company closed its previously announced Pacific Financial acquisition and recorded related expenses.

11 days ago · seekingalpha.com

Banner Corporation ( BANR ) Q3 2026 Earnings Call October 22, 2026 11:00 AM EDT Company Participants Mark J. Grescovich - President, CEO & Director Rich Arnold - Head of Investor Relations Jill Rice - Executive VP & Chief Credit Officer Robert Butterfield - Executive VP, CFO & Treasurer Conference Call Participants Ryan Payne - D.A.

12 days ago · zacks.com

The headline numbers for Banner (BANR) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

12 days ago · zacks.com

Banner (BANR) came out with quarterly earnings of $1.51 per share, missing the Zacks Consensus Estimate of $1.54 per share. This compares to earnings of $1.52 per share a year ago.

12 days ago · zacks.com

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Banner (BANR) have what it takes?

19 days ago · zacks.com

Banner (BANR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

28 days ago · seekingalpha.com

TEC:CA is the top Canadian ETF for broad-based, liquid U.S. tech and AI exposure, closely tracking its benchmark with low fees. TEC:CA's unhedged structure benefits from USD appreciation and offers superior liquidity versus Canadian peers, making it a core holding for tech allocation. Despite recent volatility and AI CapEx concerns, resilient ad spend, strong consumer data, and big tech's CapEx flexibility support a bullish stance into Q4.

2 months ago · businesswire.com

LAGUNA HILLS, Calif.--(BUSINESS WIRE)---- $ADGM #ARRHYTHMIA--Adagio Medical Holdings, Inc. (Nasdaq: ADGM) (“Adagio” or “the Company”), a leading innovator in catheter ablation technologies for the treatment of cardiac arrhythmias, today announced highlights from the first patient enrolled in the Company's study evaluating its next-generation vCLAS™ Ultra Ultra-Low Temperature Ablation (“ULTA”) Ventricular Ablation System. The study is designed to support a Premarket Approval (“PMA”) supplement to the Company's PMA f.